TickerStat.com

ANAPTYSBIO, INC (ANAB)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

11 annual periodsNewest to oldest
20252024202320222021202020192018201720162015
Revenue$234.6M$91.3M$17.2M$10.3M$63.2M$75.0M$8.0M$5.0M$10.0M$16.7M$17.6M
Research & development$136.0M$163.8M$132.3M$88.8M$98.5M$80.0M$99.3M$56.2M$29.4M$15.4M$17.3M
Operating expenses$186.7M$206.2M$181.6M$125.4M$120.0M$98.9M$115.4M$71.7M$38.8M$19.7M$20.9M
Operating income$47.9M−$114.9M−$164.4M−$115.2M−$56.8M−$23.9M−$107.4M−$66.7M−$28.8M−$3.0M−$3.3M
EBITDAderived$48.5M−$114.3M−$163.8M−$114.5M−$56.2M−$23.3M−$106.9M−$66.4M−$28.6M−$2.8M−$3.0M
Net income−$13.2M−$145.2M−$163.6M−$128.7M−$57.8M−$19.9M−$97.3M−$61.7M−$30.1M−$4.3M−$5.4M
Basic EPSper diluted share-$0.46-$5.12-$6.08-$4.57-$2.11-$0.73-$3.60-$2.50-$1.52-$1.62-$2.12
Diluted EPSper diluted share-$0.46-$5.12-$6.08-$4.57-$2.11-$0.73-$3.60-$2.50-$1.52-$1.62-$2.12
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys4$11.10M disclosed value
Sells (SEC code S)60$12.39M disclosed value
64 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Mar 30, 2026Form 4Schmid John P.DirectorSellCommon Stock522$57.40$30.0K31.6K
Mar 30, 2026Form 4Schmid John P.DirectorSellCommon Stock7.5K$56.70$426.8K32.1K
Mar 30, 2026Form 4Schmid John P.DirectorSellCommon Stock12.6K$55.71$701.7K39.7K
Mar 27, 2026Form 4Faga DanielPresident, CEOSellCommon Stock100$65.99$6.6K496.0K
Mar 27, 2026Form 4Faga DanielPresident, CEOSellCommon Stock3.0K$65.20$198.1K496.1K
Review ownership filings at SEC.gov ↗